| abstract |
The present invention relates to the use of at least one beta-adrenergic agonist in a cosmetic composition as an antagonist of substance P or for the preparation of a pharmaceutical composition, more particularly dermatological, intended to treat the disorders associated with a. excess synthesis and / or release of substance P. The invention also relates to a cosmetic or pharmaceutical composition, for topical use, comprising at least one beta-adrenergic agonist and a cosmetic treatment process for reducing the pain associated with a excess synthesis and / or release of substance P or reduce the irritant effect of a cosmetic composition. |